Olema Pharmaceuticals Inc... (OLMA)
Olema Pharmaceuticals Statistics
Share Statistics
Olema Pharmaceuticals has 68.33M shares outstanding. The number of shares has increased by 2.47% in one year.
| Shares Outstanding | 68.33M |
| Shares Change (YoY) | 2.47% |
| Shares Change (QoQ) | 0.05% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 54.63M |
| Failed to Deliver (FTD) Shares | 7.11K |
| FTD / Avg. Volume | 0.63% |
Short Selling Information
The latest short interest is 10.87M, so 15.91% of the outstanding shares have been sold short.
| Short Interest | 10.87M |
| Short % of Shares Out | 15.91% |
| Short % of Float | 20.23% |
| Short Ratio (days to cover) | 8.38 |
Valuation Ratios
The PE ratio is -6.57 and the forward PE ratio is -2.28. Olema Pharmaceuticals's PEG ratio is 0.4.
| PE Ratio | -6.57 |
| Forward PE | -2.28 |
| PS Ratio | 0 |
| Forward PS | 1.9 |
| PB Ratio | 2.5 |
| P/FCF Ratio | -7.58 |
| PEG Ratio | 0.4 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Olema Pharmaceuticals Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.33, with a Debt / Equity ratio of 0.01.
| Current Ratio | 12.33 |
| Quick Ratio | 12.33 |
| Debt / Equity | 0.01 |
| Total Debt / Capitalization | 0.94 |
| Cash Flow / Debt | -34.64 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.38% and return on capital (ROIC) is -40.95%.
| Return on Equity (ROE) | -0.38% |
| Return on Assets (ROA) | -0.35% |
| Return on Capital (ROIC) | -40.95% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1,110,977.01 |
| Employee Count | 87 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -70.61% in the last 52 weeks. The beta is 2.06, so Olema Pharmaceuticals's price volatility has been higher than the market average.
| Beta | 2.06 |
| 52-Week Price Change | -70.61% |
| 50-Day Moving Average | 5.58 |
| 200-Day Moving Average | 10.18 |
| Relative Strength Index (RSI) | 31.36 |
| Average Volume (20 Days) | 1.13M |
Income Statement
| Revenue | n/a |
| Gross Profit | -377K |
| Operating Income | -104.96M |
| Net Income | -96.66M |
| EBITDA | -104.58M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -2.14 |
Balance Sheet
The company has 68.54M in cash and 2.42M in debt, giving a net cash position of 66.12M.
| Cash & Cash Equivalents | 68.54M |
| Total Debt | 2.42M |
| Net Cash | 66.12M |
| Retained Earnings | -305.63M |
| Total Assets | 230.17M |
| Working Capital | 187.29M |
Cash Flow
In the last 12 months, operating cash flow was -83.73M and capital expenditures 0, giving a free cash flow of -83.73M.
| Operating Cash Flow | -83.73M |
| Capital Expenditures | 0 |
| Free Cash Flow | -83.73M |
| FCF Per Share | -1.85 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OLMA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -49.2% |
| FCF Yield | -28.17% |
Analyst Forecast
The average price target for OLMA is $30, which is 589.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $30 |
| Price Target Difference | 589.7% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | 2.66 |
| Piotroski F-Score | 2 |